The Correlation of Hypokalemia and Hypomagnesemia in ICU Patients: A Cross Sectional Study
Abstract
Aim & Objectives The study aims to examine the correlation between hypomagnesemia and hypokalemia, determine if there is a critical potassium level where magnesium deficiency is more likely, and analyze the severity of hypokalemia in ICU patients with hypomagnesemia. Materials and methods This cross-sectional descriptive study was conducted in the ICU of Jaslok Hospital from October 2022 to April 2024. Adult ICU patients (aged 18 years and older) with potassium levels (serum potassium ≤ 3.5 mEq/L) were included and serum magnesium levels were sent. Patients on antacids or magnesium supplements were excluded. A total of 91 patients were selected using systematic random sampling, based on a prior study showing 62% hypomagnesemia in hypokalemic patients. Data, including demographics and lab results, were extracted from electronic medical records. Statistical analyses included chi-square, Pearson correlation, and receiver operating characteristic (ROC) curve analysis. Results Hypomagnesemia prevalence was 64.84%. ROC analysis for potassium as a predictor of hypomagnesemia showed an area under the curve (AUC) of 0.652, with a potassium cut off of ≤3.1 mEq/L, sensitivity of 52.54%, and specificity of 75%. The positive predictive value (PPV) was 79.5%, and the negative predictive value (NPV) was 46.2%. The Pearson correlation coefficient between potassium and magnesium was 0.463 (p < 0.0001), indicating a moderately positive correlation and statistically significant relation…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 91 participants or records.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.